Overall rank by patents
#15,468
of 50,000 tracked assignees
USPTO PatentsView assignee record - 19 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (PEPTIDES).
The verdict
According to USPTO PatentsView, Molecular ranks #15,468 of 50,000 tracked US assignees by granted-patent volume, with 19 patents across 7 technology areas.
USPTO PatentsView assignee plate
Corpus R15468 · Foreign Corporation #15,468 · 19 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: Meridian International Co., Ltd (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Molecular Partners · this assignee
42 score
3D Lighting Innovati… · lowest
7 score
What this shows Molecular Partners Ag stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-NARROW, INNOV-PAR, CLAIMS-DENSE, TYPE-FRNCORP, VEL-DOWN, BOOK-FULL. Volume places it #15,468 of 50,000; Innovation Score 41.5/100 sits in the top 33% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Meridian International Co., Ltd (±0 grants).
Molecular Partners Ag has been granted 19 US utility patents between 2015 and 2025, placing Molecular Partners Ag at #15,468 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.5 claims per patent with primary concentration in C07K (PEPTIDES). As a Foreign Corporation, Molecular Partners Ag is one of the more focused assignees in the PatentsView dataset. By volume, Molecular sits between Meridian International Co., Ltd (19 patents, rank #15,465) and N.v. Nederlandsche Apparatenfabriek Nedap (19 patents, rank #15,473) - the closest US assignees by grant volume. The composite Innovation Score of 41.5/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 7 grants, compared with 11 in the 2015–2019 window, a -36% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Molecular Partners Ag's 22.5 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 7 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Meridian International Co., Ltd
19 patents
Metabolic Technologies, LLC
19 patents
Microlin, LLC
19 patents
Mitsubishi Electric US, Inc.
19 patents
Monotype Imaging Inc.
19 patents
Multi Packaging Solutions UK Limited
19 patents
MycoWorks, Inc.
19 patents
N.V. NEDERLANDSCHE APPARATENFABRIEK NEDAP
19 patents
Molecular Partners AG
19 patents
What this shows Molecular holds 19 patents at rank #15,469, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #15,469 in granted patent volume.
Other assignees with the most granted patents in Molecular's primary technology class.
Molecular's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
42 Top 33% higher than 67% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 10.5% |
| 2016 | 3 | 15.8% |
| 2017 | 3 | 15.8% |
| 2018 | 1 | 5.3% |
| 2019 | 2 | 10.5% |
| 2020 | 2 | 10.5% |
| 2022 | 3 | 15.8% |
| 2023 | 2 | 10.5% |
| 2025partial year | 1 | 5.3% |
Top 7 of 7 technology areas
Overall rank by patents
#15,468
of 50,000 tracked assignees
41.5 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.